Literature DB >> 8610523

Intestinal permeability measurements - a new application for water soluble contrast media?

R Andersen1, F Laerum.   

Abstract

The detection and quantification of altered intestinal barrier function (intestinal permeability) have been addressed frequently during the last year, but the tests available for determination of intestinal permeability are both flawed and have limitations. The new water-soluble roentgen contrast media (CM) of low- and iso-osmolar type have been proposed as intestinal permeability probes. In this article this possible new application for water-soluble CM is discussed in terms of their inherent properties and the experimental and clinical results obtained so far. The 2 iso-osmolar dimers, iodixanol (Visipaque) and iotrolan (Isovist), seem to be as good as the well-documented radio-labeled permeability probe (51)Cr-EDTA in detecting injury of the intestinal mucosal barrier. The CM offer the advantage of allowing direct control of bowel wall exposure with the aid of fluoroscopy. Current permeability probes lack this quality. Iodine-containing substances may be analyzed by the rapid, simple and reliable X-ray fluorescence technique, which is suitable for application in routine clinical practice. We conclude that the new water-soluble roentgen CM have properties which may be of use in the diagnosis and quantification of altered intestinal barrier function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8610523     DOI: 10.1177/0284185195036s39930

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


  3 in total

1.  Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test.

Authors:  Vanya A Gerova; Simeon G Stoynov; Dimitar S Katsarov; Dobrin A Svinarov
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats.

Authors:  Richard A Forsgård; Riitta Korpela; Reetta Holma; Jere Lindén; Rafael Frias; Thomas Spillmann; Pia Österlund
Journal:  Cancer Chemother Pharmacol       Date:  2016-09-02       Impact factor: 3.333

3.  Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA.

Authors:  Julius Z H von Martels; Arno R Bourgonje; Hermie J M Harmsen; Klaas Nico Faber; Gerard Dijkstra
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.